Conference abstracts
Management of T2D is challenging for clinicians in India. This study evaluated and demonstrated the effectiveness of the Diabefly® program for glycemic control among people with T2D, which is evident from the results of 144 participants showing a remarkable reduction in HbA1C, weight, and BMI by 1.56%, 2.39 kg and 0.84 Kg/m2 from the baseline respectively. Similarly, in users with complete blood sugar readings, a mean reduction in FBS and PPBS was observed by 53.93 mg/dL and 99.25 mg/dl from the baseline respectively.